FDA puts hold on Merck multiple myeloma trials after deaths

(Reuters) - Merck& Co said on Wednesday the U.S. Food and Drug Administration had placed a clinical hold on three multiple myeloma studies testing its Keytruda in combination with other medicines for the blood cancer after more deaths were reported in patients receiving the Merck immunotherapy.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news